LOS ANGELES CALIFORNIA, June 27, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT), a pioneer in location sensitive health monitoring devices and wearable technology products for remote patient Monitoring, announced it has signed an agreement with HandsFree Heath to offer their HFH Go Digital Health Tool, a mobile health solution designed to improve compliance and healthcare management. Included with the app will be access to a nationwide urgent care Telehealth service.
MetAlert, Inc. will begin early enrollment starting July 1st, 2023, through the HFH virtual healthcare assistant app and the MetAlert portal. This medical concierge and virtual urgent care service will enable individuals to reach a medical provider by phone, chat, or webcam within minutes, rather than hours or days, through a nationwide urgent care Telehealth service and national network of US-licensed, board-certified medical providers. The service will include diagnosis and personalized treatment plans without having to leave your home.
Some of the benefits include:
- Track your health, (blood pressure, glucose, heart rate, temperature, weight and more);
- Chart your progress;
- Set appointments and reminder notifications;
- Search for providers;
- Ask WellBe health related questions.
WellBe®, the HIPAA-compliant smart health assistant which runs on AI technology, is a voice-enabled digital health platform that keeps seniors, caregivers, families, and even businesses connected to their health and wellness.
“This is one more piece of MetAlert’s 360-degree approach to provide additional subscription services for comprehensive remote patient monitoring and long-term predictive analytics, to the ADA community we serve,” stated Patrick Bertagna MetAlert CEO. “With our patented GPS SmartSole plus, 3D infrared RoomMate for indoor remote patient monitoring, and now adding Telehealth urgent care and WellBe (your AI smart health assistant), MetAlert is able to provide a host of data collection wearable devices, wander assistance with real-time recovery, fall prevention assistance, remote urgent care assistance, and symptoms and treatment assistance, all under one platform, with easy monthly payments.”
For more information on early enrollment please visit https://metalert.com/hands-free-tele-health/
For all press or sales inquiries, please contact MetAlert at info@metalert.com
About HandsFree Health™
HandsFree Health™ offers a suite of SaaS for health and PERS needs for consumers and businesses to move individuals closer to compliance and optimal health. HandsFree Health™ makes intelligently designed, fully integrated health and wellness platforms. HandsFree Health™ has quickly become the benchmark for voice technology in healthcare. HandsFree Health™ is the creator of WellBe®, the premier voice-enabled virtual health AI assistant platform. WellBe® is a secure voice-activated assistant, built on a trusted, HIPAA-compliant platform.
Media contact: media@handsfreehealth.com
Sales contact: contactus@handsfreehealth.com
About MetAlert, Inc.:
MetAlert (OTC: MLRT) and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling, and licensing products, services, and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer, dementia, and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software, and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real time. Known for its game-changing and award-winning patented GPS SmartSole® -- think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. Military Government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers. www.MetAlert.com
Social Media:
FB: https://www.facebook.com/metalertinc
IG: https://www.instagram.com/metalert/?hl=en
Twitter: https://twitter.com/metalertinc
Linked In: https://www.linkedin.com/company/metalertinc/
YouTube: https://www.youtube.com/channel/UCUlYP1WQoLdKkDzwhGkx40Q
Forward-Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document's content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.
General information, investor relations, wholesale licensing, consumer purchase:
MetAlert, Inc.
Tel: 213.489.3019
Email: info@metalert.com or ir@metalert.com
MetAlert
United Kingdom, London
Nelson Skip Riddle
Tel: +44 7785 364100
Email: nsriddle@metalert.com
